4BASEBIO UK SOCIETAS (LON:4BB)
528p+4.46%
Spriggl Score: Weak— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Gene therapy supplier surges sales but massive losses leave binary outcome; cash runway buys time.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About 4BASEBIO UK SOCIETAS
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded …
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £79.0M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on 4BASEBIO UK SOCIETAS and 1,600+ UK and US stocks.
Start free